StockData
Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc. (KPTIQ) stock

KPTIQOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTI
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
Share price
Not available yet

Price, market cap and P/E appear here once daily prices are connected.

Karyopharm Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Karyopharm Therapeutics's price to sales ratio was 0.0× on Nov 9, 2026, against 0.3× a year earlier. Over the last 5 years it ranged from 0.0× to 5.7×, with a median of 0.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 9, 20260.0×−0.4
2025Dec 31, 20250.4×−0.1
2024Dec 31, 20240.6×−0.1
2023Dec 29, 20230.7×−0.4
2022Dec 30, 20221.1×−3.0
2021Dec 31, 20214.1×−8.4
2020Dec 31, 202012.5×−39.8
2019Dec 31, 201952.3×+34.3
2018Dec 31, 201818.0×−208.8
2014Jan 31, 2014226.7×+77.9
2013Dec 31, 2013148.9×–

More Karyopharm Therapeutics figures

See a number that looks wrong?